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OBJECTIVES We evaluated a novel protocol of dual-isotope, gated single-photon emission computed
tomographic (SPECT) imaging combined with low and high dose dobutamine as a single test
for the characterization of various types of altered myocardial dysfunction.
BACKGROUND Myocardial perfusion tomography and echocardiography have been used separately for the
assessment of myocardial viability. However, it is possible to assess perfusion, function and
contractile reserve using gated SPECT imaging.
METHODS We studied 54 patients with ischemic cardiomyopathy using rest and 4 h redistribution
thallium-201 imaging and dobutamine technetium-99m sestamibi SPECT imaging. The
sestamibi images were acquired 1 h after infusion of the maximal tolerated dose of
dobutamine and again during infusion of dobutamine at a low dose to estimate contractile
reserve. Myocardial segments were defined as hibernating, stunned, remodeled or scarred.
RESULTS Severe regional dysfunction was present in 584 (54%) of 1,080 segments. Based on the
combination of function and perfusion characteristics in these 584 segments, 24% (n 5 140)
were labeled as hibernating; 23% (n 5 136) as stunned; 30% (n 5 177) as remodeled; and
22% (n 5 131) as scarred. Contractile reserve, represented by improvement in wall
motion/thickening by low dose dobutamine, was observed in 83% of stunned, 59% of
hibernating, 35% of remodeled and 13% of scarred myocardial segments (p , 0.05).
CONCLUSIONS It is possible with this new imaging technique to characterize dysfunctional myocardium as
stunned, hibernating, remodeled and nonviable. These subtypes often coexist in the same
patient. (J Am Coll Cardiol 2000;36:1913–9) © 2000 by the American College of
Cardiology
Diagnostic evaluation for the assessment of the magnitude
of dysfunctional but viable myocardium has become an
integral component of the management of patients with
coronary artery disease (CAD) and impaired left ventricular
(LV) ejection fraction (EF) (1,2). The functional impair-
ment in these patients is not always irreversible (3–7), and
up to 40% of patients may demonstrate improvement on
restoration of blood flow to the myocardium (2,5). How-
ever, the high operative risk associated with revasculariza-
tion procedures in such patients necessitates accurate differ-
entiation of viable from nonviable myocardium (1,2).
Various noninvasive imaging procedures have been used for
the detection of reversible systolic dysfunction. Demonstra-
tion of preservation of myocardial metabolism by positron
emission tomography (PET) (8–16), determination of the
sarcolemmal membrane integrity by myocardial uptake and
retention of radioactive perfusion tracers (17–22) and echo-
cardiographic observation of contractile reserve on inotropic
stimulation (21,23–25) form the basis of assessment of
myocardial viability. Several studies have employed both
thallium scintigraphy and echocardiography for the assess-
ment of myocardial perfusion and contractile reserve in the
same patient (26,27). Although they are attractive, compar-
ative studies have the potential for anatomic malalignment,
because orientation of the heart is inherently different
between two techniques. The assessment of LV function
simultaneously with myocardial perfusion has now become
possible with gated single-photon emission computed to-
mographic (SPECT) imaging (28–30). The present study
was undertaken to evaluate the clinical feasibility of using
radionuclide imaging for the assessment of perfusion and
function in the same myocardial segments in patients with
CAD and LV dysfunction. We reasoned that knowledge of
perfusion at rest and during stress, wall motion at rest and
contractile reserve in same myocardial segment would allow
better characterization of altered myocardial states.
METHODS
Patients. We studied 54 patients of CAD and impaired
LV systolic function (EF, 25 6 10%). There were 45 men
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(83%) and 9 women (17%) (age 65 6 9 years). All patients
were studied because of angina or heart failure, or both, but
none had a recent acute myocardial infarction (,3 months),
unstable angina or primary valvular heart disease. Of those,
44 (82%) had a history of myocardial infarction and 23
(43%) had previous coronary revascularization procedures.
The risk factor profile was as follows: diabetes, 43%;
hypertension, 31%; hypercholesterolemia, 46%; smoking,
28%; and family history, 40%. Most patients were receiving
beta-blockers, calcium channel blockers, angiotensin-
converting enzyme inhibitors, digoxin or nitrates. There
were 34 patients (63%) with severe triple-vessel disease; 13
patients (24%) with two-vessel disease; and 7 patients (13%)
with single-vessel disease. All patients signed a consent
form approved by the Institutional Review Board, and there
were no complications related to the study.
Study protocol. The protocol consisted of a four-step
imaging procedure: first, two SPECT images (SPECT–1
and 2) were obtained with thallium-201 (Tl-201), and next,
two gated SPECT images (SPECT–3 and 4) were obtained
with technetium-99m (Tc-99m) sestamibi. The study pro-
tocol has been previously described (1), and is described
briefly as follows. After an overnight fast, 3.5 mCi of Tl-201
was injected intravenously at rest, and SPECT images were
obtained 20 min later (SPECT-1). The thallium SPECT
images were repeated 4 h later (redistribution images,
SPECT-2). Shortly after SPECT-2 was completed, dobut-
amine was infused to a maximal tolerated dose (up to
40 mg/kg body weight per minute). At the peak dobutamine
dose, Tc-99m sestamibi (30 mCi) was injected intrave-
nously. The dobutamine infusion was continued ’1 to
2 min after intravenous injection and stopped. Gated
SPECT sestamibi images were performed 1 h after radio-
tracer administration (SPECT-3). After acquisition of
SPECT-3 images, dobutamine was reinfused at a low dose
of 5 mg/kg per min, and gated SPECT images (SPECT-4)
were acquired during infusion. Thus, a total of four SPECT
images were acquired—two with thallium and two with
sestamibi. The total imaging protocol is ’6 h. The radia-
tion burden is comparable to a standard dual-isotope pro-
tocol or to the stress–rest sestamibi protocol.
Interpretation of SPECTimages. Data analysis was per-
formed using a 20-segment model to assess regional perfu-
sion and regional function (wall motion/thickening) using a
semiquantitative scoring system, as previously described (1).
Perfusion and function were scored on a semiquantitative
scale of 0 to 4, where 0 5 no perfusion or no wall thickening
or akinesia/dyskinesia, and 4 5 normal perfusion and
function.
Comparison of SPECT–1 and 2 images provided the
status of rest perfusion and was defined as normal; mild to
moderate fixed defect; severe fixed defect; or reversible
defect. Reversible defects provided evidence of rest isch-
emia, or hypoperfusion at rest (1,30,31).
Comparison of SPECT–1 and 3 allowed the assessment
of stress-induced ischemia. For instance, a normal segment
by SPECT–1 and 2 may become ischemic on stress by
SPECT-3, or a reversible defect by SPECT–1 and 2 may
show more severe ischemia with stress by SPECT-3 (Fig.
1).
The SPECT-3 image also provided information on
regional function in each segment (wall motion/
thickening) and LVEF. The functional data reflect base-
line or rest variables, because the images were obtained
1 h after completion of dobutamine infusion. The 1-h
interval also avoided the potential problem of post-stress
stunning (30).
The SPECT-4 image provided information on contrac-
tile reserve. An improvement in wall motion/thickening in
previously abnormal segments represented the presence of
contractile reserve. In contrast, the lack of improvement was
considered a lack of contractile reserve.
Definitions of altered myocardial states and rationale.
Based on segmental perfusion and function, the following
definitions of altered myocardial states were developed.
MYOCARDIAL HIBERNATION: Segments with severe systolic
dysfunction were called hibernating if they demonstrated
evidence of hypoperfusion at rest (rest ischemia) (3,32,33).
Therefore, the segments with regional dysfunction
(SPECT-3 wall motion score 5 0 or 1) and evidence of
reversible thallium defects (SPECT-2 perfusion score .
SPECT-1 perfusion score) were considered to represent
hibernating myocardium.
MYOCARDIAL STUNNING: The presence of function–flow
mismatch (contractile abnormality with normal perfusion)
has traditionally been considered as stunned myocardium
(34,35). Therefore, segments with regional dysfunction
(SPECT-3 wall motion score 5 0 or 1) and normal
thallium at rest or mild to moderate fixed thallium defects
(SPECT–1 and 2 perfusion score 5 2 to 4) were considered
stunned if they developed ischemia with dobutamine stress
(SPECT-3 perfusion score , SPECT-1 perfusion score).
MYOCARDIAL REMODELING: Segments with regional dys-
function (SPECT-3 wall motion score 5 0 or 1) and
normal thallium at rest or redistribution or only mild to
moderate perfusion defects (SPECT–1 and 2 perfusion
score 5 2 to 4) and no dobutamine-inducible ischemia
(SPECT-3 perfusion score 5 SPECT-1 perfusion score)
were referred as “remodeled segments” (1,31,36).
Abbreviations and Acronyms
CAD 5 coronary artery disease
EF 5 ejection fraction
LV 5 left ventricular
PET 5 positron emission tomography
SPECT 5 single-photon emission computed tomography
Tl-201 5 thallium-201
Tc-99m 5 technetium-99m
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MYOCARDIAL SCARRING: Segments with regional dysfunc-
tion (SPECT-3 wall motion score 5 0 or 1) with severe
fixed perfusion defects at rest, redistribution and stress
(SPECT–1, 2 and 3 perfusion score 5 0 or 1) were
considered as scar or irreversibly damaged myocardium.
Choice of stress imaging and dosage of pharmaceutical
stress. Dobutamine rather than exercise or vasodilator
therapy was used as a stress modality, because dobutamine
enables assessment of both stress-induced changes as well as
contractile reserve. Other forms of stress may be used if
contractile reserve assessment is not needed. All patients in
the present study had echocardiographic assessment at
baseline and during dobutamine infusion. The peak dose of
dobutamine was based on the development of a new or
worsening wall motion abnormality, conventional end
points or a maximal dose of 40 mg/kg per min. The choice
of low dose dobutamine of 5 mg/kg per min was based on
the fact that none of the patients given this dose developed
a new or worsening wall motion abnormality on two-
dimensional echocardiography. This dose was therefore
considered safe for continuous infusion while SPECT-4
was being acquired.
Follow-up. As this was a pilot study and not an outcome
study, follow-up was available in only 27 patients at a mean
interval of 25 months. The patient was considered to have
significant viability if scarring was ,40% of the myocar-
dium.
Statistical analysis. The data are presented as the mean
value 6 SD or percentage. The data were analyzed using
analysis of variance with a multiple-comparison procedure,
the Wilcoxon rank-sum test, the Student t test and the
chi-square test, as appropriate. It was clear that different
segments behaved differently in the same patient, and
therefore the analysis was based on segments. A p value
,0.05 was considered statistically significant.
RESULTS
Myocardial perfusion. Of 1,080 segments analyzed, the
thallium perfusion pattern at rest (SPECT-1) was normal in
557 segments (52%) and showed mild to moderate perfu-
sion defects in 273 segments (25%) and severe defects in 250
segments (23%). Redistribution images acquired 4 h later
(SPECT-2) demonstrated improvement in perfusion in 127
(47%) of the 273 segments with mild to moderate defects
and in 93 (37%) of 250 segments with severe defects. The
SPECT-3 images demonstrated ischemia in 223 (40%) of
557 segments with normal thallium perfusion and 159
(58%) of 273 segments with mild to moderate fixed thallium
defects.
Assessment of segmental wall motion abnormality. Of
1,080 segments, 144 (13%) demonstrated normal regional
wall motion/thickening; 352 (33%) had mild to moderate
dysfunction and 584 (54%) had severe dysfunction. The
thallium perfusion was normal in 72% of segments with
normal function and 61% of segments with mild to mod-
erate dysfunction.
Assessment of altered myocardial states. In the 584
myocardial segments with severe dysfunction, the thallium
uptake was normal in 239 segments. Dobutamine stress
demonstrated inducible ischemia in 88 (37%) of the 239
Figure 1. A, Rest and 4-h SPECT thallium images in a woman with
severe two-vessel disease and severe LV dysfunction (EF 21%). There are
severe diffuse wall motion abnormalities. The SPECT images are shown in
the short-axis (apex to base, rows 1 and 3), vertical long-axis (septum to
lateral wall, row 5) and horizontal long-axis projections (inferior wall to
septum, row 7). The corresponding 4-h redistribution images are shown in
rows 2, 4, 6 and 8 in the same orientations. There is only a mild perfusion
defect involving the septum. B, Dobutamine sestamibi and rest thallium
SPECT images from the same patient using the same format as in A. Here
the sestamibi images are displayed in rows 1, 3, 5 and 7, and the rest
thallium images in rows 2, 4, 6 and 8. There are now multiple reversible
perfusion defects with transient LV dilation. This patient has a substantial
amount of viable myocardium, and the LV dysfunction is secondary to
myocardial stunning, hibernation and remodeling.
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segments, and they were considered to represent stunned
myocardium. The remaining 151 (63%) of the 239 segments
did not have inducible ischemia and were considered to
represent remodeled segments. The perfusion score de-
creased in the stunned but not the remodeled segments (p 5
0.001) (Table 1).
The thallium uptake showed mild to moderate fixed
defects in 74 of the 584 segments with a severe wall motion
abnormality. Two-thirds of these segments showed isch-
emia on SPECT-3 and were considered to represent a
combination of stunned myocardium and mild scarring.
The thallium uptake showed reversible defects in 140 of
the 584 segments with severe systolic dysfunction. These
segments were considered to represent hibernating myocar-
dium (Fig. 1). The rest perfusion score improved from
SPECT-1 to SPECT-2 and then worsened on SPECT-3
(p 5 0.001) (Table 1). Dobutamine produced more severe
defects in 91 (65%) of the 140 segments, possibly represent-
ing a combination of hibernation and stunning.
The remaining 131 of 584 myocardial segments with a
severe contractile abnormality demonstrated severe, fixed
thallium defects. Most of these segments (n 5 105; 80%)
demonstrated no further worsening of perfusion with do-
butamine. These segments represented scarred or nonviable
myocardium. The rest thallium, delayed thallium and do-
butamine stress perfusion scores were unchanged.
Thus, 140 (24%) of 584 dysfunctional segments repre-
sented hibernating myocardium (with or without concom-
itant stunning), 136 (23%) were stunned (with and without
scarring), 177 (30%) were remodeled (with or without
scarring) and 131 (22%) were nonviable segments.
Contractile reserve in dysfunctional myocardial seg-
ments. Improvement in systolic wall motion/thickening
with low dose dobutamine was seen in 73 (83%) of the 88
stunned segments (segments with no scar); 82 (59%) of 140
hibernating segments; 53 (35%) of 151 remodeled seg-
ments; and 17 (13%) of 131 scarred segments (p , 0.05).
The contractile reserve (change in wall motion/thickening
score from SPECT-3 to SPECT-4) was higher in stunned
segments than in other segments (p 5 0.001) (Table 1). The
contractile reserve in hibernating segments was confined
predominantly to those segments that had shown worsening
of rest ischemia with high dose dobutamine. Of 91 hiber-
nating segments with inducible ischemia, 68 (75%) demon-
strated positive contractile reserve, as compared with 14
(29%) of 49 segments with no evidence of inducible isch-
emia (p , 0.05).
Follow-up. Of the 27 patients with follow-up data, 4
underwent coronary revascularization and 23 were treated
medically. Twelve of 23 patients had predominantly viable
and 11 had nonviable myocardium; 5 and 3 of these
patients, respectively, either died or had heart transplanta-
tion. The number of patients in each group was too small to
allow meaningful statistical comparison.
DISCUSSION
The results of the present study document different patho-
physiologic mechanisms (stunning, hibernation, remodeling
and scarring) for LV dysfunction in patients with ischemic
cardiomyopathy. Within a given myocardial region, more
than one feature may exist, and in a given patient, one or
more of the aforementioned features may predominate.
These results are based on a novel protocol used in the
present study that allowed precise registration of regional
myocardial perfusion (at rest and during stress) with re-
gional function (at baseline and in response to low dose
dobutamine) using dual-isotope, gated SPECT imaging.
Assessment of reversible LV dysfunction. Previous stud-
ies show that the coronary flow reserve is abnormal in
regions with reversible LV dysfunction (37). The limited
flow reserve may result in dysfunction secondary to repeti-
tive stunning (flow–function mismatch). In contrast, a
reduction in rest myocardial flow has also been reported in
viable dysfunctional segments (flow–function match). Im-
aging with PET has shown flow–metabolism mismatch in
both forms of reversible LV dysfunction (8,9). Such mis-
match in the presence of normal rest flow suggests an
alteration in the pattern of substrate utilization, probably
related to changes in activity of glucose transporters (13,14).
Previous SPECT studies have shown that myocardial
tracer activity is a marker of viable myocardium (17–22).
Good correlation between tracer activity and the degree of
fibrosis has been reported in biopsy specimens and ex-
transplanted hearts. (38,39). Although in many studies a
threshold was used to define viable myocardium, the prob-
ability of recovery of function correlates with uptake as a
continuum, and no single threshold could accurately distin-
guish regions that recover from those that do not recover
after coronary revascularization (40). These studies, how-














Normal 4.0 6 0.0 4.0 6 0.0 4.0 6 0.0 4.0 6 0.0 4.0 6 0.0 NA
Stunned 4.0 6 0.0 4.0 6 0.0 1.1 6 0.7* 1.0 6 0.2 3.4 6 1.2† 2.5 6 1.2
Remodeled 4.0 6 0.0 4.0 6 0.0 4.0 6 0.0 0.9 6 0.2 1.4 6 0.8† 0.5 6 0.8‡
Hibernating 1.7 6 0.8 3.0 6 0.7* 0.8 6 0.6* 0.6 6 0.5 1.5 6 1.0† 0.9 6 1.0‡
Scar 0.5 6 0.5 0.5 6 0.5 0.5 6 0.5 0.3 6 0.4 0.4 6 0.8 0.2 6 0.8‡
*p , 0.001 as compared with rest perfusion. †p , 0.001 as compared with rest wall motion. ‡p , 0.001 as compared with stunned, true. Data are presented as mean 6 SD.
NA 5 not applicable; SPECT 5 single-photon emission computed tomography.
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ever, relied on independent methods to assess perfusion and
function, with inherent problems in segment registration.
Viability has traditionally been defined as an improve-
ment in regional wall motion after coronary revasculariza-
tion (41,42). It is clear, however, that 1) recovery of regional
function could not be the only benefit of revascularization of
viable myocardium; and 2) myocardial viability may exist,
even though recovery of function could not be demon-
strated. Lack of recovery may be due to subendocardial
fibrosis, remodeling, incomplete revascularization or ad-
vanced ultrastructural, biochemical and metabolic alter-
ations that may require a much longer period to recover, if
at all (13,14).
Restoration of blood supply to the viable myocardium
may provide clinical benefit by eliminating life-threatening
ventricular arrhythmias, preventing LV dilation, improving
exercise function, improving diastolic function and prevent-
ing repetitive stunning (16,43–48). These changes may
result in improvement of quality of life and survival. It has
been recently proposed that continued low grade ischemia,
particularly in the subendocardial layers, might lead to
apoptosis (49,50). The process of apoptosis, a genetically
programmed cell death, occurs when the ischemic insult is
delivered in doses milder than that required for necrosis.
Apoptosis may also occur in terminally differentiated myo-
cytes that are exposed to constant growth stimulus in the
failing myocardium. The myocytes respond by hypertrophy
initially, but undergo apoptosis because they fail to replicate
(51,52). Prevention of apoptosis and an inexorable loss of
myocytes may contribute to reverse remodeling and recovery
of LV function gradually over many months.
The present study: identification of altered myocardial
states. The present study showed that different pathophys-
iologic states might explain LV dysfunction, and these
might coexist in the same patient, in the same vascular
territory or even in the same segment. These altered states
include hibernation, stunning, remodeling and scarring.
These classifications were made possible by evaluating rest
and stress-induced ischemia, as well as rest and contractile
response with dual-isotope, gated SPECT imaging. Previ-
ous studies have shown that tracer uptake is normal in
stunned myocardium, but is decreased in regions with low
flow (53). Myocardial segments with systolic dysfunction
but normal perfusion at rest and no stress-induced ischemia
were considered to represent remodeled segments (36); such
segments may represent compensatory changes in remote
segments with no coronary stenosis, and their ultimate faith
might depend on the associated changes elsewhere in the
myocardium. It is important to note that dobutamine
induced further ischemia in most segments that were
classified as hibernating with reduced rest flow. This may
explain why such segments may not improve function with
inotropic stimulation. Detection of ischemia is important in
predicting recovery of function after coronary revasculariza-
tion. Kitsiou et al. (54) demonstrated that 79% of myocar-
dial segments with reversible defects improved after coro-
nary artery bypass graft surgery, as compared with 30% of
segments with mild to moderate fixed defects.
In our study, stunned segments were more likely to show
positive contractile reserve, as compared with hibernating
segments, which is in agreement with other reports. In one
study, 54% of hibernating segments did not demonstrate
contractile reserve (55), and the myocardial blood flow
during dobutamine stress was lower in hibernating segments
with no contractile reserve, as compared to those segments
with contractile reserve. Sambuceti et al. (56) also showed
that contractile response was more common in stunned than
in hibernating myocardium.
Study limitations. Several limitations of the present study
need to be considered. First, the data on postoperative
assessment of LV function are not available. However, as
discussed earlier, recovery of function may not be the
optimal gold standard. Second, we used a small dose of
dobutamine for the assessment of contractile reserve. It has
been suggested that contractile reserve in some patients may
require a higher dose, although the relation of contractile
reserve with recovery of LV function remains to be elicited
(57). Third, it is also possible that some of the remodeled
segments may have shown evidence of ischemia if the dose
of dobutamine was higher. As indicated in the Methods
section, dobutamine infusion was discontinued when a new
or worsening wall motion abnormality was demonstrated by
two-dimensional echocardiography. This may be a draw-
back of using an echocardiographic end point. Dobutamine,
as used in nuclear imaging, follows a more standard protocol
using clinical end points rather than wall motion abnormal-
ity. Fourth, our measurements of wall motion/thickening
were based on subjective interpretation of the gated SPECT
images, which may have their own limitations. Several
studies, including our own, have shown good correlation
between wall motion/thickening assessment by gated
SPECT and other independent methods, such as two-
dimensional echocardiography and magnetic resonance im-
aging (27,28). It is now possible, however, to use a com-
pletely automated method for the assessment of both wall
motion and wall thickening using gated SPECT imaging.
Conclusions. Myocardial hibernation, stunning, remodel-
ing and scarring often coexist in patients with ischemic
cardiomyopathy. Approximately 50% of the myocardium in
our patients was either stunned or hibernating, or both.
Future studies need to examine the relation of the type of
altered myocardial states with recovery of function and
patient outcome, with or without surgical revascularization.
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